The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
6-Benzyl-4-(((6-(benzyloxy)-2-hydroxyquinolin-3-yl)methylene)amino)-3-thioxo-3,4-dihydro-1,2,4-triazin-5(2H)-one ID: ALA4867950
PubChem CID: 164621852
Max Phase: Preclinical
Molecular Formula: C27H21N5O3S
Molecular Weight: 495.56
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: O=c1c(Cc2ccccc2)n[nH]c(=S)n1/N=C/c1cc2cc(OCc3ccccc3)ccc2nc1O
Standard InChI: InChI=1S/C27H21N5O3S/c33-25-21(14-20-15-22(11-12-23(20)29-25)35-17-19-9-5-2-6-10-19)16-28-32-26(34)24(30-31-27(32)36)13-18-7-3-1-4-8-18/h1-12,14-16H,13,17H2,(H,29,33)(H,31,36)/b28-16+
Standard InChI Key: YGFBHDLSZNZFIU-LQKURTRISA-N
Molfile:
RDKit 2D
36 40 0 0 0 0 0 0 0 0999 V2000
28.2412 -10.8216 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.2401 -11.6411 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.9481 -12.0501 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.9463 -10.4127 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.6549 -10.8180 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.6557 -11.6370 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.3642 -12.0440 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
31.0725 -11.6332 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.0678 -10.8111 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.3587 -10.4077 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.7730 -10.3982 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.4832 -10.8025 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
33.1884 -10.3896 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
33.8964 -10.7966 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.5995 -10.3871 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.5988 -9.5696 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
33.8887 -9.1631 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
33.1794 -9.5742 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.4692 -9.1701 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
33.8987 -11.6137 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
35.3082 -10.7941 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.0149 -10.3839 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.7194 -10.7925 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.4257 -10.3829 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.4242 -9.5649 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.7106 -9.1581 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.0072 -9.5700 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.7818 -12.0391 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
27.5334 -10.4131 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
26.8258 -10.8219 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.1180 -10.4135 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.1214 -9.5957 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.4145 -9.1873 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.7059 -9.5962 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.7087 -10.4176 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.4162 -10.8222 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 5 1 0
9 11 1 0
11 12 2 0
12 13 1 0
13 14 1 0
13 18 1 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 1 0
18 19 2 0
14 20 2 0
15 21 1 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 22 1 0
8 28 1 0
1 29 1 0
29 30 1 0
30 31 1 0
31 32 2 0
32 33 1 0
33 34 2 0
34 35 1 0
35 36 2 0
36 31 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 495.56Molecular Weight (Monoisotopic): 495.1365AlogP: 4.61#Rotatable Bonds: 7Polar Surface Area: 105.39Molecular Species: NEUTRALHBA: 8HBD: 2#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 7.36CX Basic pKa: 1.35CX LogP: 6.01CX LogD: 5.74Aromatic Rings: 5Heavy Atoms: 36QED Weighted: 0.25Np Likeness Score: -1.12
References 1. Ghanim AM, Rezq S, Ibrahim TS, Romero DG, Kothayer H.. (2021) Novel 1,2,4-triazine-quinoline hybrids: The privileged scaffolds as potent multi-target inhibitors of LPS-induced inflammatory response via dual COX-2 and 15-LOX inhibition., 219 [PMID:33892270 ] [10.1016/j.ejmech.2021.113457 ]